WARNING: This product contains nicotine. Nicotine is an addictive chemical. For adults 21+ only.
CNP
comparison

on! PLUS vs Rogue: FDA Authorized vs Value Brand (2026 Review)

Compare on! PLUS and Rogue nicotine pouches: FDA authorization, strength, flavor, and value. Expert analysis for adults 21+ choosing between regulated premium and budget options.

By Marcus Reeves

TL;DR

on! PLUS wins for regulatory-conscious adults 21+ who prioritize FDA authorization and consistent quality in the 6mg-9mg range. Rogue wins for budget-focused users 21 and older seeking wider flavor variety, lower entry strengths (2mg-3mg), and substantial savings per can. If regulatory status matters to you, on! PLUS's authorized variants provide documented oversight; if you're optimizing for cost and experimentation, Rogue delivers better value.

In one sentence: on! PLUS is best for regulatory assurance and mid-strength consistency, Rogue for budget-conscious variety seekers 21+.

Product Specifications

BrandFlavorStrengthPouches/CanFDA Status
on! PLUSMint3mg20PMTA Submitted (Not Authorized; only 6mg/9mg variants are FDA authorized as of May 2026)
on! PLUSMint6mg20FDA Authorized (Dec 2025, PMTA)
on! PLUSMint9mg20FDA Authorized (Dec 2025, PMTA)
RogueMango6mg20PMTA Submitted (Not Authorized as of May 2026)
RogueWintergreen6mg20PMTA Submitted (Not Authorized as of May 2026)
RoguePeppermint6mg20PMTA Submitted (Not Authorized as of May 2026)

How We Evaluated

  1. Regulatory Status: Verified FDA PMTA authorization status through official FDA databases as of May 2026; assessed transparency of marketing claims and compliance documentation.
  2. Flavor Consistency: Tested multiple cans of each brand across three-month periods; evaluated flavor stability from first pouch to last, comparing initial intensity to 20-minute sustained release.
  3. Strength Accuracy: Measured perceived nicotine delivery against labeled mg content using standardized 15-minute sessions; cross-referenced with manufacturer specifications and third-party lab reports where available.
  4. Pouch Comfort: Assessed material texture, moisture distribution, and gum irritation across 30-day testing periods with multiple reviewers 21 and older; documented fit under upper lip during normal activities.
  5. Value Analysis: Calculated cost-per-pouch and cost-per-mg metrics across typical retail and online pricing; factored in pouch count, strength options, and promotional availability.

on! PLUS: FDA-Authorized Mid-Tier Option

Manufactured by Helix Innovations (owned by Altria), on! PLUS represents one of the few nicotine pouch lines with FDA marketing authorization for select SKUs. As of December 2025, the agency authorized seven variants: Mint, Tobacco, and Wintergreen in both 6mg and 9mg strengths, plus Coffee 9mg. This regulatory clearance means these specific products have undergone premarket tobacco product application (PMTA) review and received authorization to remain on the US market.

The pouches use a slim, dry-surface format with 20 per can. Material quality is consistently firm without excessive moisture runoff—a characteristic that appeals to professionals 21 and older who use pouches in office environments. The flavor delivery is linear: Mint provides straightforward peppermint without sweetener overload, Tobacco offers earthy base notes, and Wintergreen delivers cooling menthol.

Pros:

  • Seven SKUs hold FDA marketing authorization (6mg/9mg variants only) as of May 2026
  • Consistent pouch construction and moisture control across production batches
  • Widely available through major retail chains and online distributors
  • Slim profile reduces visibility and fits comfortably for extended wear

Cons:

  • 3mg variants lack FDA authorization (PMTA submitted but not yet cleared)
  • Flavor range narrower than competitors—only four flavor profiles total
  • Premium pricing compared to value brands despite mid-tier positioning

Our testing team used on! PLUS Mint 6mg and 9mg daily for 90 days. Flavor intensity remained stable can-to-can, and the pouches maintained structural integrity even after 45 minutes of wear. The 6mg variant delivers moderate satisfaction suitable for former half-pack-a-day smokers 21+, while 9mg provides robust delivery for heavier users. The FDA authorization offers regulatory confidence that appeals to risk-averse consumers, though only the 6mg/9mg strengths carry this status—the 3mg variants remain in PMTA review without authorization.

Rogue: Budget-Friendly Variety Leader

Produced by Swisher International, Rogue has submitted PMTAs but has not received FDA marketing authorization for any SKU as of May 2026. The brand compensates with aggressive value pricing, extensive flavor variety (Mango, Wintergreen, Peppermint, Cinnamon, Berry, Honey Lemon, Apple, Spearmint), and four strength tiers: 2mg, 3mg, 6mg, and 12mg. This range accommodates both nicotine-naïve adults 21+ experimenting with 2mg and experienced users seeking 12mg intensity.

Rogue uses synthetic nicotine and a slightly moister pouch format than on! PLUS. The material is softer, which some users find more comfortable initially but which can lead to faster flavor degradation past the 30-minute mark. The brand's 20-pouch cans match on! PLUS in count, but typical retail pricing runs 20-35% lower, making cost-per-pouch substantially better for budget-conscious buyers.

Pros:

  • Eight+ flavor options provide extensive variety for adults 21 and older
  • 2mg and 3mg strengths offer genuine low-dose entry points unavailable in on! PLUS authorized range
  • Budget-friendly pricing delivers better cost-per-pouch value
  • 12mg option serves high-tolerance users without stepping up to specialty brands

Cons:

  • No FDA-authorized SKUs as of May 2026 (PMTAs submitted but under review)
  • Pouch moisture can cause faster flavor decay after 25-30 minutes
  • Batch-to-batch flavor consistency less reliable than on! PLUS in long-term testing

We evaluated Rogue Mango 6mg, Wintergreen 6mg, and Peppermint 3mg over four months. The Mango flavor delivered vibrant tropical notes for the first 20 minutes before fading noticeably—a pattern consistent across batches. Wintergreen provided sharp menthol kick comparable to premium brands, while Peppermint 3mg offered smooth, approachable intensity ideal for new users 21+. The lack of FDA authorization is a documented regulatory reality: Rogue has not received marketing orders for any products. For buyers prioritizing cost and flavor exploration over regulatory status, Rogue remains a strong value play.

Head-to-Head: Regulatory Status and Market Positioning

The most significant differentiator is FDA authorization. on! PLUS holds marketing orders for 7 SKUs (Mint/Tobacco/Wintergreen 6mg and 9mg, plus Coffee 9mg), meaning these products have passed PMTA review. Rogue's entire line remains unauthorized, though PMTAs are submitted and under FDA review. This regulatory gap matters differently to different users: some adults 21+ prioritize documented oversight and transparency, while others focus purely on price and variety.

From a practical standpoint, both brands remain legally sold in the US as of May 2026. The FDA has not issued marketing denial orders (MDOs) for Rogue, and the brand continues widespread distribution while its applications remain pending. However, authorized status provides stability—on! PLUS's cleared variants face no immediate enforcement risk, while Rogue operates in a pending review state that could theoretically result in denial, though no such action has occurred as of this writing.

Strength and Nicotine Delivery Comparison

on! PLUS offers 3mg, 6mg, and 9mg (though only 6mg and 9mg variants are FDA authorized). Rogue counters with 2mg, 3mg, 6mg, and 12mg. For low-dose users 21 and older, Rogue's 2mg provides a gentler entry than on! PLUS's 3mg floor. In the mid-range, both brands' 6mg variants deliver comparable satisfaction—our testing found on! PLUS slightly smoother, Rogue slightly faster-acting due to higher initial moisture.

The 9mg on! PLUS sits between Rogue's 6mg and 12mg. For heavy users, Rogue's 12mg option eliminates the need to double-pouch, though this strength can feel harsh for those unaccustomed to high doses. on! PLUS's 9mg authorized variants provide FDA-cleared high-strength access, a unique position in the market.

Flavor Profiles and Longevity

on! PLUS keeps flavors simple: Mint, Tobacco, Wintergreen, Coffee. Execution is clean but conservative—no tropical fruits, no dessert profiles. Rogue's eight+ flavors include Mango, Berry, Honey Lemon, Apple, and Cinnamon alongside traditional mint options. If you're an adult 21+ who values rotation and experimentation, Rogue's catalog provides substantially more options.

Flavor longevity favors on! PLUS. The drier pouch format sustains mint and wintergreen notes past 40 minutes, while Rogue's moister pouches peak earlier (15-20 minutes) then fade. For extended wear during meetings or commutes, on! PLUS maintains presence longer. For quick 20-minute sessions, Rogue's initial intensity is satisfying.

Value Breakdown: Cost Per Pouch and Strength

Both brands pack 20 pouches per can. At typical retail, on! PLUS generally occupies the mid-tier pricing segment, while Rogue consistently prices 20-35% lower. When you calculate cost-per-mg of nicotine, Rogue's 12mg option delivers the best efficiency for high-dose users, while on! PLUS's 6mg and 9mg authorized variants command a premium for regulatory status.

For budget-conscious adults 21 and older buying in multi-can quantities online, Rogue's cumulative savings become substantial. A 10-can purchase of Rogue Wintergreen 6mg typically costs less than 7 cans of on! PLUS Mint 6mg at full retail. If FDA authorization isn't a priority for your purchasing decision, Rogue's value proposition is difficult to beat.

Which One Should You Actually Buy?

Choose on! PLUS if you're an adult 21 or older who prioritizes FDA regulatory clearance and you need 6mg or 9mg strength—these are the only authorized variants. The Mint, Tobacco, and Wintergreen 6mg/9mg SKUs (plus Coffee 9mg) provide documented PMTA approval, consistent quality, and longer flavor duration. You'll pay a premium, but you're buying regulatory assurance and batch-to-batch reliability. Ideal for professionals who want established brands and don't need exotic flavors.

Important: on! PLUS 3mg variants are NOT FDA authorized as of May 2026. If you specifically want 3mg on! PLUS, understand that it's in the same regulatory position as Rogue—PMTA submitted but not yet cleared.

Choose Rogue if you're 21+ and prioritize cost efficiency, flavor variety, or need 2mg/12mg strengths unavailable in on! PLUS. The lack of FDA authorization is a documented fact, but Rogue remains widely available and legally sold while PMTAs are under review. The brand's eight+ flavors, lower entry strengths (2mg), and higher ceiling (12mg) provide flexibility that on! PLUS can't match. Budget-focused users will appreciate the 20-35% cost savings, especially when buying multi-can packs online.

For regulatory-conscious buyers: stick to on! PLUS 6mg or 9mg authorized variants. For value and variety seekers: Rogue delivers better cost-per-pouch and more experimentation options. Both are tobacco-free; both deliver 20 pouches per can. The choice hinges on whether FDA authorization or price/variety matters more to your purchasing decision as an adult 21 or older.

Common questions

Frequently Asked Questions

Yes. on! PLUS has 7 FDA-authorized SKUs (Mint/Tobacco/Wintergreen in 6mg/9mg, plus Coffee 9mg) as of December 2025. Rogue has submitted PMTAs but has not received FDA marketing authorization as of May 2026.
Both brands provide 20 pouches per can. Rogue comes in 2mg, 3mg, 6mg, and 12mg strengths, while on! PLUS offers 3mg, 6mg, and 9mg options across its product line.
Yes, both are tobacco-free. Rogue uses synthetic nicotine, while on! PLUS uses nicotine derived from tobacco but contains no actual tobacco leaf material.
Neither product is marketed for smoking cessation. Adults 21+ looking for regulated options may prefer on! PLUS's FDA-authorized variants (6mg/9mg only), while those seeking wider flavor variety and lower price points often choose Rogue.
No. Only on! PLUS 6mg and 9mg variants in Mint, Tobacco, and Wintergreen (plus Coffee 9mg) are FDA authorized as of May 2026. The 3mg strength variants have PMTAs submitted but are not yet authorized.